Retrospective analysis of complete remission in cases with advanced non-small cell lung cancer - Retrospective analysis of complete remission in cases with advanced non-small cell lung cancer

Respiratory Division, Department of Internal Medicine, Tokai University School of Medicine0 个研究点目标入组 443 人开始时间: 2019年6月18日最近更新: 2023年10月17日

研究概览

简要总结

There were 164 stage III and 279 stage IV patients, with 37 (22.6%) and 51 (18.3%) long-term survivors and 12 (7.3%) and 5 (1.8%) complete remission (CR) patients, respectively. The cured stage IV patients had smaller primary tumors and fewer metastases at initial diagnoses.

研究设计

研究类型: Observational

入排标准

年龄范围: 20years-old 至 99years-old（—）
性别: All

入选标准

未提供

排除标准

•No exclusion criteria

研究者

发起方

Respiratory Division, Department of Internal Medicine, Tokai University School of Medicine

相似试验

已完成

3 期

Multicenter study of a randomized controlled trial with or without maintenance/intensification therapy in patients with previously untreated acute promyelocytic leukemia (JALSG APL97 study)acute promyelocytic leukemia (APL)

JPRN-C000000206Japan Adult Leukemia Study Group234

已完成

不适用

Retrospective Analysis for Long-Term Survivors in advanced non-small cell lung canceron-small Cell Lung Cancer

JPRN-UMIN000006913Kansai Respiratory Clinical Network Research Group500

进行中（未招募）

不适用

A 3-Phase Study to Evaluate Sustained Remission and Productivity Outcomes in Subjects With Early Rheumatoid Arthritis Initiated on Treatment With Etanercept Plus Methotrexate - PRIZEModerate to severe early Rheumatoid Arthritis (RA).MedDRA version: 12.0Level: LLTClassification code 10039073Term: Rheumatoid arthritis

EUCTR2008-002623-85-ITWyeth Research Division of Wyeth Pharmaceuticals Inc. Clinical Research and Development300

已完成

2 期

Phase II Dose-Ranging Study in Subjects With Mild to Moderate Ulcerative Colitis Treated With SPD476Colitis, Ulcerative

NCT00545389Shire38

进行中（未招募）

2 期

Study to Evaluate the Reinduction and Second Stop of TKI with Ponatinib in CML in Molecular Response (ResToP)Chronic Myeloid Leukemia, Chronic Phase

NCT04160546Fundacion CRIS de Investigación para Vencer el Cáncer80